Skip to main content
The New England Journal of Medicine homepage

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Published March 17, 2020
N Engl J Med 2020;382:1564-1567
DOI: 10.1056/NEJMc2004973

To the Editor:

A novel human coronavirus that is now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (formerly called HCoV-19) emerged in Wuhan, China, in late 2019 and is now causing a pandemic.1 We analyzed the aerosol and surface stability of SARS-CoV-2 and compared it with SARS-CoV-1, the most closely related human coronavirus.2
We evaluated the stability of SARS-CoV-2 and SARS-CoV-1 in aerosols and on various surfaces and estimated their decay rates using a Bayesian regression model (see the Methods section in the Supplementary Appendix, available with the full text of this letter at NEJM.org). SARS-CoV-2 nCoV-WA1-2020 (MN985325.1) and SARS-CoV-1 Tor2 (AY274119.3) were the strains used. Aerosols (<5 μm) containing SARS-CoV-2 (105.25 50% tissue-culture infectious dose [TCID50] per milliliter) or SARS-CoV-1 (106.75-7.00 TCID50 per milliliter) were generated with the use of a three-jet Collison nebulizer and fed into a Goldberg drum to create an aerosolized environment. The inoculum resulted in cycle-threshold values between 20 and 22, similar to those observed in samples obtained from the upper and lower respiratory tract in humans.
Our data consisted of 10 experimental conditions involving two viruses (SARS-CoV-2 and SARS-CoV-1) in five environmental conditions (aerosols, plastic, stainless steel, copper, and cardboard). All experimental measurements are reported as means across three replicates.
SARS-CoV-2 remained viable in aerosols throughout the duration of our experiment (3 hours), with a reduction in infectious titer from 103.5 to 102.7 TCID50 per liter of air. This reduction was similar to that observed with SARS-CoV-1, from 104.3 to 103.5 TCID50 per milliliter (Figure 1A).
Figure 1
Viability of SARS-CoV-1 and SARS-CoV-2 in Aerosols and on Various Surfaces.
As shown in Panel A, the titer of aerosolized viable virus is expressed in 50% tissue-culture infectious dose (TCID50) per liter of air. Viruses were applied to copper, cardboard, stainless steel, and plastic maintained at 21 to 23°C and 40% relative humidity over 7 days. The titer of viable virus is expressed as TCID50 per milliliter of collection medium. All samples were quantified by end-point titration on Vero E6 cells. Plots show the means and standard errors (𝙸 bars) across three replicates. As shown in Panel B, regression plots indicate the predicted decay of virus titer over time; the titer is plotted on a logarithmic scale. Points show measured titers and are slightly jittered (i.e., their horizontal positions are modified by a small random amount to reduce overlap) along the time axis to avoid overplotting. Lines are random draws from the joint posterior distribution of the exponential decay rate (negative of the slope) and intercept (initial virus titer) to show the range of possible decay patterns for each experimental condition. There were 150 lines per panel, including 50 lines from each plotted replicate. As shown in Panel C, violin plots indicate posterior distribution for the half-life of viable virus based on the estimated exponential decay rates of the virus titer. The dots indicate the posterior median estimates, and the black lines indicate a 95% credible interval. Experimental conditions are ordered according to the posterior median half-life of SARS-CoV-2. The dashed lines indicate the limit of detection, which was 3.33×100.5 TCID50 per liter of air for aerosols, 100.5 TCID50 per milliliter of medium for plastic, steel, and cardboard, and 101.5 TCID50 per milliliter of medium for copper.
SARS-CoV-2 was more stable on plastic and stainless steel than on copper and cardboard, and viable virus was detected up to 72 hours after application to these surfaces (Figure 1A), although the virus titer was greatly reduced (from 103.7 to 100.6 TCID50 per milliliter of medium after 72 hours on plastic and from 103.7 to 100.6 TCID50 per milliliter after 48 hours on stainless steel). The stability kinetics of SARS-CoV-1 were similar (from 103.4 to 100.7 TCID50 per milliliter after 72 hours on plastic and from 103.6 to 100.6 TCID50 per milliliter after 48 hours on stainless steel). On copper, no viable SARS-CoV-2 was measured after 4 hours and no viable SARS-CoV-1 was measured after 8 hours. On cardboard, no viable SARS-CoV-2 was measured after 24 hours and no viable SARS-CoV-1 was measured after 8 hours (Figure 1A).
Both viruses had an exponential decay in virus titer across all experimental conditions, as indicated by a linear decrease in the log10TCID50 per liter of air or milliliter of medium over time (Figure 1B). The half-lives of SARS-CoV-2 and SARS-CoV-1 were similar in aerosols, with median estimates of approximately 1.1 to 1.2 hours and 95% credible intervals of 0.64 to 2.64 for SARS-CoV-2 and 0.78 to 2.43 for SARS-CoV-1 (Figure 1C, and Table S1 in the Supplementary Appendix). The half-lives of the two viruses were also similar on copper. On cardboard, the half-life of SARS-CoV-2 was longer than that of SARS-CoV-1. The longest viability of both viruses was on stainless steel and plastic; the estimated median half-life of SARS-CoV-2 was approximately 5.6 hours on stainless steel and 6.8 hours on plastic (Figure 1C). Estimated differences in the half-lives of the two viruses were small except for those on cardboard (Figure 1C). Individual replicate data were noticeably “noisier” (i.e., there was more variation in the experiment, resulting in a larger standard error) for cardboard than for other surfaces (Fig. S1 through S5), so we advise caution in interpreting this result.
We found that the stability of SARS-CoV-2 was similar to that of SARS-CoV-1 under the experimental circumstances tested. This indicates that differences in the epidemiologic characteristics of these viruses probably arise from other factors, including high viral loads in the upper respiratory tract and the potential for persons infected with SARS-CoV-2 to shed and transmit the virus while asymptomatic.3,4 Our results indicate that aerosol and fomite transmission of SARS-CoV-2 is plausible, since the virus can remain viable and infectious in aerosols for hours and on surfaces up to days (depending on the inoculum shed). These findings echo those with SARS-CoV-1, in which these forms of transmission were associated with nosocomial spread and super-spreading events,5 and they provide information for pandemic mitigation efforts.
Neeltje van Doremalen, Ph.D.
Trenton Bushmaker, B.Sc.
National Institute of Allergy and Infectious Diseases, Hamilton, MT
Dylan H. Morris, M.Phil. https://orcid.org/0000-0002-3655-406X
Princeton University, Princeton, NJ
Myndi G. Holbrook, B.Sc.
National Institute of Allergy and Infectious Diseases, Hamilton, MT
Amandine Gamble, Ph.D.
University of California, Los Angeles, Los Angeles, CA
Brandi N. Williamson, M.P.H.
National Institute of Allergy and Infectious Diseases, Hamilton, MT
Azaibi Tamin, Ph.D.
Jennifer L. Harcourt, Ph.D.
Natalie J. Thornburg, Ph.D.
Susan I. Gerber, M.D.
Centers for Disease Control and Prevention, Atlanta, GA
James O. Lloyd-Smith, Ph.D. https://orcid.org/0000-0001-7941-502X
University of California, Los Angeles, Los Angeles, CA, Bethesda, MD
Emmie de Wit, Ph.D.
Vincent J. Munster, Ph.D.
National Institute of Allergy and Infectious Diseases, Hamilton, MT [email protected]

Notes

The findings and conclusions in this letter are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC). Names of specific vendors, manufacturers, or products are included for public health and informational purposes; inclusion does not imply endorsement of the vendors, manufacturers, or products by the CDC or the Department of Health and Human Services.
This letter was published on March 17, 2020, at NEJM.org.
Dr. van Doremalen, Mr. Bushmaker, and Mr. Morris contributed equally to this letter.
Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and by contracts from the Defense Advanced Research Projects Agency (DARPA PREEMPT No. D18AC00031, to Drs. Lloyd-Smith and Gamble), from the National Science Foundation (DEB-1557022, to Dr. Lloyd-Smith), and from the Strategic Environmental Research and Development Program of the Department of Defense (SERDP, RC-2635, to Dr. Lloyd-Smith).
Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.

Supplementary Material

Supplementary Appendix (nejmc2004973_appendix.pdf)
Disclosure Forms (nejmc2004973_disclosures.pdf)

References

1.
Coronavirus disease (COVID-2019) situation reports. Geneva: World Health Organization, 2020 (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/).
2.
Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020;27:325-328.
3.
Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020 February 21 (Epub ahead of print).
4.
Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382:1177-1179.
5.
Chen YC, Huang LM, Chan CC, et al. SARS in hospital emergency room. Emerg Infect Dis 2004;10:782-788.

Information & Authors

Information

Published In

New England Journal of Medicine
Pages: 1564-1567

History

Published online: March 17, 2020
Published in issue: April 16, 2020

Topics

Authors

Authors

Neeltje van Doremalen, Ph.D.1, Trenton Bushmaker, B.Sc.1, Dylan H. Morris, M.Phil.2 https://orcid.org/0000-0002-3655-406X, Myndi G. Holbrook, B.Sc.3, Amandine Gamble, Ph.D.4, Brandi N. Williamson, M.P.H.5, Azaibi Tamin, Ph.D.6, Jennifer L. Harcourt, Ph.D.6, Natalie J. Thornburg, Ph.D.6, Susan I. Gerber, M.D.6, James O. Lloyd-Smith, Ph.D.7 https://orcid.org/0000-0001-7941-502X, Emmie de Wit, Ph.D.8, and Vincent J. Munster, Ph.D.8

Affiliations

1National Institute of Allergy and Infectious Diseases, Hamilton, MT
2Princeton University, Princeton, NJ
3National Institute of Allergy and Infectious Diseases, Hamilton, MT
4University of California, Los Angeles, Los Angeles, CA
5National Institute of Allergy and Infectious Diseases, Hamilton, MT
6Centers for Disease Control and Prevention, Atlanta, GA
7University of California, Los Angeles, Los Angeles, CA, Bethesda, MD
8National Institute of Allergy and Infectious Diseases, Hamilton, MT
[email protected]

Metrics & Citations

Metrics

Altmetrics

Citations

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Fluctuation in SARS-CoV-2 Environmental Surface Contamination Levels in Homes Where Patients With COVID-19 Stayed for Recuperation, Cureus, (2024).https://doi.org/10.7759/cureus.52055
    Crossref
  2. Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster, eLife, 12, (2024).https://doi.org/10.7554/eLife.87094.3
    Crossref
  3. Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster, eLife, 12, (2024).https://doi.org/10.7554/eLife.87094
    Crossref
  4. Aerosol and Droplet Dispersion Control during Bronchoscopy Using a Newly Developed Oxygen Mask, Respiratory Endoscopy, 2, 1, (25-31), (2024).https://doi.org/10.58585/respend.2023-0037
    Crossref
  5. Ensino presencial e remoto durante a pandemia e incidência de COVID-19 em uma Universidade da Baixada Fluminense, Cuadernos de Educación y Desarrollo, 16, 3, (e3550), (2024).https://doi.org/10.55905/cuadv16n3-016
    Crossref
  6. Maske Takma Davranışının, Saldırganlık ve Bilişsel Esneklik Açısından İncelenmesi, Dünya İnsan Bilimleri Dergisi, 2024, 1, (76-95), (2024).https://doi.org/10.55543/insan.1318140
    Crossref
  7. Responding to challenge call for machine learning model development in diagnosing respiratory disease sounds, Journal of Edge Computing, (2024).https://doi.org/10.55056/jec.679
    Crossref
  8. Guidelines for dental implants in the times of COVID-19, National Journal of Maxillofacial Surgery, 15, 1, (23-28), (2024).https://doi.org/10.4103/njms.njms_450_21
    Crossref
  9. Cryptococcus laurentii: A rare and serious fungal infection, and a rising cause of concern in post-COVID-19 era, International Journal of Academic Medicine, 10, 1, (40-42), (2024).https://doi.org/10.4103/ijam.ijam_55_23
    Crossref
  10. Impact of Novel Coronavirus Pandemic on Emergency and Elective Surgical Practice: A Retrospective Study in a Tertiary Care Center, CHRISMED Journal of Health and Research, 10, 3, (263-273), (2024).https://doi.org/10.4103/cjhr.cjhr_74_23
    Crossref
  11. See more
Loading...

View Options

View options

PDF

View PDF

Media

Figures

Other

Tables

Share

Share

CONTENT LINK

Share